Analysts at StockNews.com assumed coverage on shares of United-Guardian (NASDAQ:UG – Get Rating) in a report issued on Friday. The brokerage set a “buy” rating on the stock.
United-Guardian Trading Down 12.9 %
Shares of NASDAQ:UG opened at $9.06 on Friday. The stock’s 50-day moving average price is $11.15 and its two-hundred day moving average price is $11.89. United-Guardian has a 12-month low of $9.06 and a 12-month high of $26.09. The firm has a market cap of $41.62 million, a price-to-earnings ratio of 16.18 and a beta of 0.51.
Hedge Funds Weigh In On United-Guardian
Hedge funds and other institutional investors have recently modified their holdings of the company. Rockefeller Capital Management L.P. lifted its stake in shares of United-Guardian by 29.6% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 7,001 shares of the company’s stock valued at $79,000 after purchasing an additional 1,600 shares in the last quarter. UBS Group AG raised its holdings in shares of United-Guardian by 7.3% during the 1st quarter. UBS Group AG now owns 17,657 shares of the company’s stock valued at $401,000 after buying an additional 1,207 shares during the period. Ameritas Advisory Services LLC purchased a new stake in shares of United-Guardian during the 4th quarter valued at about $458,000. Neuberger Berman Group LLC raised its holdings in shares of United-Guardian by 66.6% during the 1st quarter. Neuberger Berman Group LLC now owns 93,340 shares of the company’s stock valued at $2,123,000 after buying an additional 37,300 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of United-Guardian by 1.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 107,356 shares of the company’s stock valued at $2,420,000 after buying an additional 1,694 shares during the period. 24.40% of the stock is owned by institutional investors and hedge funds.
United-Guardian, Inc develops and manufactures pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The firm conducts research and product development related to the development of new and unique cosmetic and personal care products. The company was founded by Alfred R.
- Get a free copy of the StockNews.com research report on United-Guardian (UG)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.